Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.97117839 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.97117839 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.63949607 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.63949607 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.36602674 |
6 | cysteine metabolic process (GO:0006534) | 5.78876241 |
7 | tryptophan catabolic process (GO:0006569) | 5.78053719 |
8 | indole-containing compound catabolic process (GO:0042436) | 5.78053719 |
9 | indolalkylamine catabolic process (GO:0046218) | 5.78053719 |
10 | behavioral response to nicotine (GO:0035095) | 5.72000873 |
11 | kynurenine metabolic process (GO:0070189) | 5.55977109 |
12 | glyoxylate metabolic process (GO:0046487) | 5.55326748 |
13 | lysine metabolic process (GO:0006553) | 5.48002694 |
14 | lysine catabolic process (GO:0006554) | 5.48002694 |
15 | tryptophan metabolic process (GO:0006568) | 5.44537074 |
16 | bile acid biosynthetic process (GO:0006699) | 5.37775343 |
17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29981659 |
18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.24516765 |
19 | sulfur amino acid catabolic process (GO:0000098) | 4.98074351 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94542730 |
21 | serine family amino acid catabolic process (GO:0009071) | 4.93109863 |
22 | urea cycle (GO:0000050) | 4.91645068 |
23 | urea metabolic process (GO:0019627) | 4.91645068 |
24 | homocysteine metabolic process (GO:0050667) | 4.73893002 |
25 | cellular ketone body metabolic process (GO:0046950) | 4.66413653 |
26 | amino-acid betaine metabolic process (GO:0006577) | 4.65947675 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.61481785 |
28 | protein carboxylation (GO:0018214) | 4.61481785 |
29 | aromatic amino acid family metabolic process (GO:0009072) | 4.61243703 |
30 | bile acid metabolic process (GO:0008206) | 4.58037531 |
31 | complement activation, alternative pathway (GO:0006957) | 4.56426937 |
32 | nitrogen cycle metabolic process (GO:0071941) | 4.53246832 |
33 | alpha-amino acid catabolic process (GO:1901606) | 4.52455537 |
34 | high-density lipoprotein particle remodeling (GO:0034375) | 4.51304913 |
35 | negative regulation of fibrinolysis (GO:0051918) | 4.49410320 |
36 | fucose catabolic process (GO:0019317) | 4.43729355 |
37 | L-fucose metabolic process (GO:0042354) | 4.43729355 |
38 | L-fucose catabolic process (GO:0042355) | 4.43729355 |
39 | regulation of fibrinolysis (GO:0051917) | 4.39163883 |
40 | regulation of protein activation cascade (GO:2000257) | 4.38604444 |
41 | glutamate metabolic process (GO:0006536) | 4.37773008 |
42 | short-chain fatty acid metabolic process (GO:0046459) | 4.32653461 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 4.31333040 |
44 | cellular amino acid catabolic process (GO:0009063) | 4.26260178 |
45 | tyrosine metabolic process (GO:0006570) | 4.25640046 |
46 | triglyceride homeostasis (GO:0070328) | 4.11963933 |
47 | acylglycerol homeostasis (GO:0055090) | 4.11963933 |
48 | regulation of complement activation (GO:0030449) | 4.11406084 |
49 | indolalkylamine metabolic process (GO:0006586) | 4.09669299 |
50 | drug transmembrane transport (GO:0006855) | 4.08056125 |
51 | drug catabolic process (GO:0042737) | 4.08027764 |
52 | cellular modified amino acid catabolic process (GO:0042219) | 4.07863537 |
53 | coenzyme catabolic process (GO:0009109) | 4.07598678 |
54 | serine family amino acid metabolic process (GO:0009069) | 4.06974812 |
55 | urate metabolic process (GO:0046415) | 4.06506251 |
56 | aspartate family amino acid catabolic process (GO:0009068) | 4.05905192 |
57 | acetyl-CoA metabolic process (GO:0006084) | 4.05733712 |
58 | ketone body metabolic process (GO:1902224) | 4.00507871 |
59 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.97236764 |
60 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96274310 |
61 | protein-lipid complex remodeling (GO:0034368) | 3.96028770 |
62 | macromolecular complex remodeling (GO:0034367) | 3.96028770 |
63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.96028770 |
64 | cellular glucuronidation (GO:0052695) | 3.93707423 |
65 | amine catabolic process (GO:0009310) | 3.93015314 |
66 | cellular biogenic amine catabolic process (GO:0042402) | 3.93015314 |
67 | ethanol oxidation (GO:0006069) | 3.92679484 |
68 | reverse cholesterol transport (GO:0043691) | 3.92518440 |
69 | negative regulation of cholesterol transport (GO:0032375) | 3.89920914 |
70 | negative regulation of sterol transport (GO:0032372) | 3.89920914 |
71 | fatty acid beta-oxidation (GO:0006635) | 3.86381944 |
72 | fatty acid oxidation (GO:0019395) | 3.83716744 |
73 | benzene-containing compound metabolic process (GO:0042537) | 3.82460816 |
74 | glycine metabolic process (GO:0006544) | 3.81551640 |
75 | carboxylic acid catabolic process (GO:0046395) | 3.80785198 |
76 | organic acid catabolic process (GO:0016054) | 3.80785198 |
77 | regulation of cholesterol esterification (GO:0010872) | 3.77857366 |
78 | lipid oxidation (GO:0034440) | 3.77273064 |
79 | bile acid and bile salt transport (GO:0015721) | 3.76362603 |
80 | valine metabolic process (GO:0006573) | 3.75841395 |
81 | fatty acid catabolic process (GO:0009062) | 3.67226647 |
82 | exogenous drug catabolic process (GO:0042738) | 3.66987304 |
83 | monocarboxylic acid catabolic process (GO:0072329) | 3.66564430 |
84 | plasma lipoprotein particle clearance (GO:0034381) | 3.62644307 |
85 | serine family amino acid biosynthetic process (GO:0009070) | 3.61226562 |
86 | carnitine metabolic process (GO:0009437) | 3.58315268 |
87 | regulation of cholesterol homeostasis (GO:2000188) | 3.54625831 |
88 | imidazole-containing compound metabolic process (GO:0052803) | 3.53621751 |
89 | positive regulation of lipid catabolic process (GO:0050996) | 3.53606849 |
90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.52038271 |
91 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.51822313 |
92 | glucuronate metabolic process (GO:0019585) | 3.51352330 |
93 | uronic acid metabolic process (GO:0006063) | 3.51352330 |
94 | phospholipid efflux (GO:0033700) | 3.50394563 |
95 | branched-chain amino acid catabolic process (GO:0009083) | 3.49277169 |
96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.43660757 |
97 | indole-containing compound metabolic process (GO:0042430) | 3.43207966 |
98 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.42148714 |
99 | branched-chain amino acid metabolic process (GO:0009081) | 3.38884119 |
100 | arginine metabolic process (GO:0006525) | 3.38607166 |
101 | phospholipid homeostasis (GO:0055091) | 3.36862062 |
102 | cholesterol efflux (GO:0033344) | 3.35485063 |
103 | negative regulation of lipase activity (GO:0060192) | 3.35047013 |
104 | flavonoid metabolic process (GO:0009812) | 3.34722135 |
105 | piRNA metabolic process (GO:0034587) | 3.33462484 |
106 | drug transport (GO:0015893) | 3.31043873 |
107 | aldehyde catabolic process (GO:0046185) | 3.29875243 |
108 | sulfation (GO:0051923) | 3.29764149 |
109 | gamma-aminobutyric acid transport (GO:0015812) | 3.26578183 |
110 | biotin metabolic process (GO:0006768) | 3.25694334 |
111 | DNA deamination (GO:0045006) | 3.19880486 |
112 | oxidative demethylation (GO:0070989) | 3.08872046 |
113 | primary amino compound metabolic process (GO:1901160) | 3.06443662 |
114 | response to pheromone (GO:0019236) | 3.03521359 |
115 | negative regulation of mast cell activation (GO:0033004) | 3.01393535 |
116 | serotonin metabolic process (GO:0042428) | 2.99576540 |
117 | neural tube formation (GO:0001841) | 2.99238881 |
118 | positive regulation of fatty acid oxidation (GO:0046321) | 2.98505788 |
119 | DNA methylation involved in gamete generation (GO:0043046) | 2.98487664 |
120 | regulation of action potential (GO:0098900) | 2.97902657 |
121 | cAMP catabolic process (GO:0006198) | 2.97381681 |
122 | detection of light stimulus involved in visual perception (GO:0050908) | 2.94564921 |
123 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.94564921 |
124 | regulation of hippo signaling (GO:0035330) | 2.93168132 |
125 | interkinetic nuclear migration (GO:0022027) | 2.92841504 |
126 | neuronal action potential (GO:0019228) | 2.88144069 |
127 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.86609204 |
128 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.86609204 |
129 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.86609204 |
130 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.86196563 |
131 | regulation of sequestering of triglyceride (GO:0010889) | 2.85645465 |
132 | somite development (GO:0061053) | 2.74467996 |
133 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.73377394 |
134 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.73377394 |
135 | NADH dehydrogenase complex assembly (GO:0010257) | 2.73377394 |
136 | behavioral response to ethanol (GO:0048149) | 2.71098887 |
137 | NAD biosynthetic process (GO:0009435) | 2.70215077 |
138 | platelet dense granule organization (GO:0060155) | 2.68626511 |
139 | positive regulation of fatty acid transport (GO:2000193) | 2.68059055 |
140 | kidney morphogenesis (GO:0060993) | 2.65912361 |
141 | regulation of gene silencing by RNA (GO:0060966) | 2.64950306 |
142 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.64950306 |
143 | regulation of gene silencing by miRNA (GO:0060964) | 2.64950306 |
144 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64576186 |
145 | reflex (GO:0060004) | 2.64460743 |
146 | protein K11-linked deubiquitination (GO:0035871) | 2.63599167 |
147 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.61162399 |
148 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60700015 |
149 | cellular response to ATP (GO:0071318) | 2.59207730 |
150 | synaptic transmission, cholinergic (GO:0007271) | 2.59129818 |
151 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.58983295 |
152 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.57332195 |
153 | cyclic nucleotide catabolic process (GO:0009214) | 2.57112516 |
154 | S-adenosylmethionine metabolic process (GO:0046500) | 2.55628966 |
155 | regulation of mesoderm development (GO:2000380) | 2.53883199 |
156 | rhodopsin mediated signaling pathway (GO:0016056) | 2.53035733 |
157 | L-methionine salvage (GO:0071267) | 2.50331201 |
158 | L-methionine biosynthetic process (GO:0071265) | 2.50331201 |
159 | amino acid salvage (GO:0043102) | 2.50331201 |
160 | spinal cord motor neuron differentiation (GO:0021522) | 2.49685380 |
161 | nonmotile primary cilium assembly (GO:0035058) | 2.49144386 |
162 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49001506 |
163 | axoneme assembly (GO:0035082) | 2.47081332 |
164 | regulation of memory T cell differentiation (GO:0043380) | 2.46886486 |
165 | regulation of glucokinase activity (GO:0033131) | 2.46754614 |
166 | regulation of hexokinase activity (GO:1903299) | 2.46754614 |
167 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.46482046 |
168 | multicellular organism reproduction (GO:0032504) | 2.46280338 |
169 | protein polyglutamylation (GO:0018095) | 2.46241085 |
170 | nephron tubule morphogenesis (GO:0072078) | 2.45938081 |
171 | nephron epithelium morphogenesis (GO:0072088) | 2.45938081 |
172 | male meiosis I (GO:0007141) | 2.45897019 |
173 | dopamine transport (GO:0015872) | 2.44810309 |
174 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.43883781 |
175 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.42349904 |
176 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.42313222 |
177 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.42313222 |
178 | protein complex biogenesis (GO:0070271) | 2.41656844 |
179 | regulation of establishment of cell polarity (GO:2000114) | 2.41547979 |
180 | negative regulation of telomere maintenance (GO:0032205) | 2.41521588 |
181 | protein localization to cilium (GO:0061512) | 2.40821577 |
182 | protein-cofactor linkage (GO:0018065) | 2.40207472 |
183 | methionine biosynthetic process (GO:0009086) | 2.40156396 |
184 | reciprocal DNA recombination (GO:0035825) | 2.39246274 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.27664627 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.15410627 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.78646465 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.49382874 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.07137767 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.66214229 |
7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78290019 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.73683546 |
9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.44893215 |
10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.19805443 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.85158158 |
12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.68942411 |
13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.57515498 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.38013445 |
15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.33718554 |
16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.27751301 |
17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17923643 |
18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.12891895 |
19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.02826046 |
20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2161984 |
21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.98057328 |
22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96767209 |
23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94525033 |
24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93107124 |
25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.87521212 |
26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77765393 |
27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75361109 |
28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67889267 |
29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67808316 |
30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.65338295 |
31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.64681698 |
32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.63292131 |
33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60987467 |
34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.60670269 |
35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59650276 |
36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57102473 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50837958 |
38 | TCF4_23295773_ChIP-Seq_U87_Human | 1.49172993 |
39 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.47089491 |
40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45373995 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44767065 |
42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43204067 |
43 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41099335 |
44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41099335 |
45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40777359 |
46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40349894 |
47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39338522 |
48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38338325 |
49 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34370615 |
50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33519045 |
51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33216348 |
52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32354253 |
53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32349512 |
54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32062915 |
55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31305144 |
56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30106628 |
57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29602054 |
58 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27181333 |
59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25219919 |
60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24620595 |
61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23227938 |
62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23227938 |
63 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21446813 |
64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20632269 |
65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20510518 |
66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.20092930 |
67 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.20092930 |
68 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18916475 |
69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15624569 |
70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.14655812 |
71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13300402 |
72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13217648 |
73 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13055213 |
74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12954336 |
75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10459012 |
76 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10429725 |
77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09417231 |
78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08995697 |
79 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08596602 |
80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08463134 |
81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07920469 |
82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07920469 |
83 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07428382 |
84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07301499 |
85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06409041 |
86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06093580 |
87 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05758500 |
88 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05650000 |
89 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04704174 |
90 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04155604 |
91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04128790 |
92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03451834 |
93 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01839581 |
94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01520755 |
95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01366539 |
96 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01316826 |
97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00248005 |
98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99335711 |
99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99299769 |
100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98582513 |
101 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97737271 |
102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97355581 |
103 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96049808 |
104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95640159 |
105 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95635248 |
106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94806024 |
107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92540265 |
108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91715202 |
109 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.91490752 |
110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88617160 |
111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88159573 |
112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87718416 |
113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87127604 |
114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85337565 |
115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84191704 |
116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83051169 |
117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82818283 |
118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80762334 |
119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80451248 |
120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80238291 |
121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80079458 |
122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78918248 |
123 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76275075 |
124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74309025 |
125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72419661 |
126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72330435 |
127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72176572 |
128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71906150 |
129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71418517 |
130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67916213 |
131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.66548437 |
132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.65098572 |
133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.63578013 |
134 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63276398 |
135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.62897242 |
136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62766542 |
137 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.62720930 |
138 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.62676599 |
139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.62047411 |
140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61387363 |
141 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.59810397 |
142 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.58698071 |
143 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57852187 |
144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57312228 |
145 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.57282253 |
146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.57123687 |
147 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.56760705 |
148 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56535115 |
149 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.56329559 |
150 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.55180709 |
151 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.54781743 |
152 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.54592772 |
153 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53938450 |
154 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53631897 |
155 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.53462604 |
156 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53043375 |
157 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.52948033 |
158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.52624367 |
159 | P300_19829295_ChIP-Seq_ESCs_Human | 0.52093808 |
160 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.51854296 |
161 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.51748149 |
162 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.50967604 |
163 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50760365 |
164 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.50371045 |
165 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.50161932 |
166 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.50161932 |
167 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.49961238 |
168 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.49899411 |
169 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.48776021 |
170 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.48632526 |
171 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.48619334 |
172 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48584510 |
173 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48481377 |
174 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.48471821 |
175 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48217880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.86203489 |
2 | MP0005360_urolithiasis | 7.35304164 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.96902108 |
4 | MP0005365_abnormal_bile_salt | 5.89373743 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73839522 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.68819202 |
7 | MP0003252_abnormal_bile_duct | 3.59943485 |
8 | MP0010329_abnormal_lipoprotein_level | 3.34913219 |
9 | MP0005332_abnormal_amino_acid | 3.19387918 |
10 | MP0000569_abnormal_digit_pigmentation | 3.09070762 |
11 | MP0003195_calcinosis | 3.00612584 |
12 | MP0005083_abnormal_biliary_tract | 2.88265943 |
13 | MP0001666_abnormal_nutrient_absorption | 2.72682949 |
14 | MP0005551_abnormal_eye_electrophysiolog | 2.44628970 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.44038418 |
16 | MP0003136_yellow_coat_color | 2.29631551 |
17 | MP0009840_abnormal_foam_cell | 2.27453470 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.21122275 |
19 | MP0008877_abnormal_DNA_methylation | 2.14291053 |
20 | MP0001968_abnormal_touch/_nociception | 2.04519195 |
21 | MP0001501_abnormal_sleep_pattern | 2.03833897 |
22 | MP0003191_abnormal_cellular_cholesterol | 1.99360965 |
23 | MP0000427_abnormal_hair_cycle | 1.98958771 |
24 | MP0000609_abnormal_liver_physiology | 1.97623585 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.96048437 |
26 | MP0002102_abnormal_ear_morphology | 1.95807085 |
27 | MP0009745_abnormal_behavioral_response | 1.88327740 |
28 | MP0002638_abnormal_pupillary_reflex | 1.85878871 |
29 | MP0001986_abnormal_taste_sensitivity | 1.85586065 |
30 | MP0004885_abnormal_endolymph | 1.83211366 |
31 | MP0003868_abnormal_feces_composition | 1.81872974 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.79608130 |
33 | MP0002653_abnormal_ependyma_morphology | 1.77197918 |
34 | MP0009046_muscle_twitch | 1.76818950 |
35 | MP0001485_abnormal_pinna_reflex | 1.75132882 |
36 | MP0002736_abnormal_nociception_after | 1.70921324 |
37 | MP0004142_abnormal_muscle_tone | 1.68214726 |
38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64070103 |
39 | MP0009643_abnormal_urine_homeostasis | 1.63427156 |
40 | MP0005451_abnormal_body_composition | 1.62376254 |
41 | MP0002272_abnormal_nervous_system | 1.60100973 |
42 | MP0005174_abnormal_tail_pigmentation | 1.58938244 |
43 | MP0001764_abnormal_homeostasis | 1.57231679 |
44 | MP0006292_abnormal_olfactory_placode | 1.55204722 |
45 | MP0004145_abnormal_muscle_electrophysio | 1.46798858 |
46 | MP0000631_abnormal_neuroendocrine_gland | 1.42633501 |
47 | MP0004130_abnormal_muscle_cell | 1.39518694 |
48 | MP0005253_abnormal_eye_physiology | 1.39256052 |
49 | MP0006276_abnormal_autonomic_nervous | 1.38484135 |
50 | MP0006072_abnormal_retinal_apoptosis | 1.36831431 |
51 | MP0002160_abnormal_reproductive_system | 1.36818538 |
52 | MP0010386_abnormal_urinary_bladder | 1.36085310 |
53 | MP0000383_abnormal_hair_follicle | 1.33245623 |
54 | MP0004133_heterotaxia | 1.33175240 |
55 | MP0002735_abnormal_chemical_nociception | 1.32550970 |
56 | MP0004215_abnormal_myocardial_fiber | 1.32072707 |
57 | MP0002938_white_spotting | 1.31007399 |
58 | MP0004043_abnormal_pH_regulation | 1.30539464 |
59 | MP0005645_abnormal_hypothalamus_physiol | 1.28909452 |
60 | MP0005636_abnormal_mineral_homeostasis | 1.27514825 |
61 | MP0001486_abnormal_startle_reflex | 1.25224917 |
62 | MP0003186_abnormal_redox_activity | 1.23190859 |
63 | MP0002876_abnormal_thyroid_physiology | 1.23106422 |
64 | MP0002064_seizures | 1.21350122 |
65 | MP0002837_dystrophic_cardiac_calcinosis | 1.20521638 |
66 | MP0005389_reproductive_system_phenotype | 1.19032985 |
67 | MP0005535_abnormal_body_temperature | 1.16192690 |
68 | MP0000372_irregular_coat_pigmentation | 1.15199211 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 1.14676361 |
70 | MP0002572_abnormal_emotion/affect_behav | 1.14537015 |
71 | MP0005670_abnormal_white_adipose | 1.12307019 |
72 | MP0005084_abnormal_gallbladder_morpholo | 1.10993825 |
73 | MP0003890_abnormal_embryonic-extraembry | 1.08687287 |
74 | MP0005647_abnormal_sex_gland | 1.08653652 |
75 | MP0003283_abnormal_digestive_organ | 1.08652805 |
76 | MP0005386_behavior/neurological_phenoty | 1.07035390 |
77 | MP0004924_abnormal_behavior | 1.07035390 |
78 | MP0006036_abnormal_mitochondrial_physio | 1.07027240 |
79 | MP0009697_abnormal_copulation | 1.06164524 |
80 | MP0002733_abnormal_thermal_nociception | 1.05759887 |
81 | MP0000604_amyloidosis | 1.05237475 |
82 | MP0005171_absent_coat_pigmentation | 1.05149324 |
83 | MP0003787_abnormal_imprinting | 1.04109049 |
84 | MP0001970_abnormal_pain_threshold | 1.02293812 |
85 | MP0002067_abnormal_sensory_capabilities | 1.00632200 |
86 | MP0002557_abnormal_social/conspecific_i | 1.00309097 |
87 | MP0005379_endocrine/exocrine_gland_phen | 0.99903025 |
88 | MP0002971_abnormal_brown_adipose | 0.99096188 |
89 | MP0002078_abnormal_glucose_homeostasis | 0.98364871 |
90 | MP0005195_abnormal_posterior_eye | 0.97947550 |
91 | MP0004742_abnormal_vestibular_system | 0.97777328 |
92 | MP0003329_amyloid_beta_deposits | 0.97422112 |
93 | MP0000598_abnormal_liver_morphology | 0.96727681 |
94 | MP0003137_abnormal_impulse_conducting | 0.96237251 |
95 | MP0003011_delayed_dark_adaptation | 0.95105191 |
96 | MP0001756_abnormal_urination | 0.94472809 |
97 | MP0009764_decreased_sensitivity_to | 0.93376945 |
98 | MP0005377_hearing/vestibular/ear_phenot | 0.93270725 |
99 | MP0003878_abnormal_ear_physiology | 0.93270725 |
100 | MP0002822_catalepsy | 0.92133772 |
101 | MP0001919_abnormal_reproductive_system | 0.91819396 |
102 | MP0005666_abnormal_adipose_tissue | 0.90718119 |
103 | MP0001984_abnormal_olfaction | 0.89309041 |
104 | MP0000647_abnormal_sebaceous_gland | 0.88550362 |
105 | MP0002234_abnormal_pharynx_morphology | 0.87812367 |
106 | MP0003690_abnormal_glial_cell | 0.87761001 |
107 | MP0003880_abnormal_central_pattern | 0.87697282 |
108 | MP0008775_abnormal_heart_ventricle | 0.87406379 |
109 | MP0002063_abnormal_learning/memory/cond | 0.87092110 |
110 | MP0001765_abnormal_ion_homeostasis | 0.86192903 |
111 | MP0003879_abnormal_hair_cell | 0.85274084 |
112 | MP0009642_abnormal_blood_homeostasis | 0.85083210 |
113 | MP0000026_abnormal_inner_ear | 0.84696090 |
114 | MP0001661_extended_life_span | 0.83925311 |
115 | MP0002095_abnormal_skin_pigmentation | 0.82391982 |
116 | MP0005334_abnormal_fat_pad | 0.82244414 |
117 | MP0003635_abnormal_synaptic_transmissio | 0.81426220 |
118 | MP0005220_abnormal_exocrine_pancreas | 0.79952726 |
119 | MP0001502_abnormal_circadian_rhythm | 0.79888364 |
120 | MP0005187_abnormal_penis_morphology | 0.79499476 |
121 | MP0005408_hypopigmentation | 0.77044045 |
122 | MP0009763_increased_sensitivity_to | 0.77023304 |
123 | MP0005410_abnormal_fertilization | 0.76665439 |
124 | MP0004085_abnormal_heartbeat | 0.75646170 |
125 | MP0005423_abnormal_somatic_nervous | 0.74496744 |
126 | MP0003698_abnormal_male_reproductive | 0.72880878 |
127 | MP0002229_neurodegeneration | 0.72750407 |
128 | MP0002136_abnormal_kidney_physiology | 0.72073412 |
129 | MP0003705_abnormal_hypodermis_morpholog | 0.71529590 |
130 | MP0008469_abnormal_protein_level | 0.71105482 |
131 | MP0005376_homeostasis/metabolism_phenot | 0.70044765 |
132 | MP0010234_abnormal_vibrissa_follicle | 0.69423385 |
133 | MP0004185_abnormal_adipocyte_glucose | 0.67657235 |
134 | MP0010368_abnormal_lymphatic_system | 0.67596751 |
135 | MP0009765_abnormal_xenobiotic_induced | 0.64623237 |
136 | MP0000230_abnormal_systemic_arterial | 0.60890747 |
137 | MP0006035_abnormal_mitochondrial_morpho | 0.60285227 |
138 | MP0005448_abnormal_energy_balance | 0.59755599 |
139 | MP0004147_increased_porphyrin_level | 0.59328643 |
140 | MP0008874_decreased_physiological_sensi | 0.58589530 |
141 | MP0002254_reproductive_system_inflammat | 0.57112258 |
142 | MP0003953_abnormal_hormone_level | 0.56066533 |
143 | MP0003638_abnormal_response/metabolism_ | 0.55335729 |
144 | MP0003646_muscle_fatigue | 0.54107098 |
145 | MP0005395_other_phenotype | 0.53886585 |
146 | MP0005266_abnormal_metabolism | 0.53392168 |
147 | MP0009780_abnormal_chondrocyte_physiolo | 0.52127280 |
148 | MP0003075_altered_response_to | 0.51479163 |
149 | MP0001881_abnormal_mammary_gland | 0.50808773 |
150 | MP0000639_abnormal_adrenal_gland | 0.50493980 |
151 | MP0002168_other_aberrant_phenotype | 0.49623181 |
152 | MP0009384_cardiac_valve_regurgitation | 0.49288221 |
153 | MP0002928_abnormal_bile_duct | 0.47322386 |
154 | MP0005646_abnormal_pituitary_gland | 0.47198693 |
155 | MP0005166_decreased_susceptibility_to | 0.46466170 |
156 | MP0004782_abnormal_surfactant_physiolog | 0.43893588 |
157 | MP0008961_abnormal_basal_metabolism | 0.43421080 |
158 | MP0005375_adipose_tissue_phenotype | 0.43051497 |
159 | MP0009115_abnormal_fat_cell | 0.42280505 |
160 | MP0000538_abnormal_urinary_bladder | 0.40470907 |
161 | MP0003633_abnormal_nervous_system | 0.40331352 |
162 | MP0003718_maternal_effect | 0.39924376 |
163 | MP0003724_increased_susceptibility_to | 0.39040700 |
164 | MP0005167_abnormal_blood-brain_barrier | 0.38934175 |
165 | MP0005058_abnormal_lysosome_morphology | 0.38375315 |
166 | MP0008872_abnormal_physiological_respon | 0.37789863 |
167 | MP0001944_abnormal_pancreas_morphology | 0.35857831 |
168 | MP0002796_impaired_skin_barrier | 0.34032335 |
169 | MP0001177_atelectasis | 0.33868677 |
170 | MP0005595_abnormal_vascular_smooth | 0.32894198 |
171 | MP0003959_abnormal_lean_body | 0.31567584 |
172 | MP0002970_abnormal_white_adipose | 0.30946892 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.46419942 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.28313133 |
3 | Deep venous thrombosis (HP:0002625) | 6.13688660 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.54064076 |
5 | Xanthomatosis (HP:0000991) | 5.41303470 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 5.23323406 |
7 | Hypobetalipoproteinemia (HP:0003563) | 5.00123921 |
8 | Hyperglycinuria (HP:0003108) | 4.89485691 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.77570205 |
10 | Pancreatic cysts (HP:0001737) | 4.77354732 |
11 | Hyperglycinemia (HP:0002154) | 4.76452722 |
12 | Ketosis (HP:0001946) | 4.68292069 |
13 | Hyperammonemia (HP:0001987) | 4.59846998 |
14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.59317511 |
15 | Abnormality of glycine metabolism (HP:0010895) | 4.59317511 |
16 | Complement deficiency (HP:0004431) | 4.48378058 |
17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33382997 |
18 | Hypoglycemic coma (HP:0001325) | 4.15854530 |
19 | Abnormality of midbrain morphology (HP:0002418) | 4.10373741 |
20 | Molar tooth sign on MRI (HP:0002419) | 4.10373741 |
21 | Pancreatic fibrosis (HP:0100732) | 4.08159965 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04876235 |
23 | Nephronophthisis (HP:0000090) | 4.03957754 |
24 | Epidermoid cyst (HP:0200040) | 3.96508911 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96322431 |
26 | Ketoacidosis (HP:0001993) | 3.93711360 |
27 | Hypolipoproteinemia (HP:0010981) | 3.91464398 |
28 | Gout (HP:0001997) | 3.90917355 |
29 | True hermaphroditism (HP:0010459) | 3.90128461 |
30 | Joint hemorrhage (HP:0005261) | 3.81523934 |
31 | Congenital stationary night blindness (HP:0007642) | 3.77637807 |
32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77435003 |
33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.71187502 |
34 | Abnormality of methionine metabolism (HP:0010901) | 3.65501265 |
35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64324295 |
36 | Fat malabsorption (HP:0002630) | 3.63972039 |
37 | Abnormality of alanine metabolism (HP:0010916) | 3.63496192 |
38 | Hyperalaninemia (HP:0003348) | 3.63496192 |
39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.63496192 |
40 | Hypoalphalipoproteinemia (HP:0003233) | 3.60202537 |
41 | Genetic anticipation (HP:0003743) | 3.52052681 |
42 | Abnormality of the renal medulla (HP:0100957) | 3.47587900 |
43 | Abnormality of purine metabolism (HP:0004352) | 3.46606354 |
44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39378478 |
45 | Abnormality of the renal cortex (HP:0011035) | 3.34481459 |
46 | Type II lissencephaly (HP:0007260) | 3.31593626 |
47 | Progressive cerebellar ataxia (HP:0002073) | 3.28944432 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 3.27760125 |
49 | Chronic hepatic failure (HP:0100626) | 3.25887617 |
50 | Delayed CNS myelination (HP:0002188) | 3.22770066 |
51 | Tubular atrophy (HP:0000092) | 3.22471489 |
52 | Abnormality of serum amino acid levels (HP:0003112) | 3.19429548 |
53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.18591543 |
54 | Abnormality of the intrinsic pathway (HP:0010989) | 3.17994653 |
55 | Abnormality of complement system (HP:0005339) | 3.08367014 |
56 | Metabolic acidosis (HP:0001942) | 3.02705055 |
57 | Dicarboxylic aciduria (HP:0003215) | 2.97660328 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97660328 |
59 | Generalized aminoaciduria (HP:0002909) | 2.92662323 |
60 | Hypercholesterolemia (HP:0003124) | 2.92168581 |
61 | Inability to walk (HP:0002540) | 2.91685455 |
62 | Pendular nystagmus (HP:0012043) | 2.91370037 |
63 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.90067667 |
64 | Hyperbilirubinemia (HP:0002904) | 2.88626311 |
65 | Gaze-evoked nystagmus (HP:0000640) | 2.85736423 |
66 | Abnormal drinking behavior (HP:0030082) | 2.85443803 |
67 | Polydipsia (HP:0001959) | 2.85443803 |
68 | Steatorrhea (HP:0002570) | 2.82551591 |
69 | Hyperuricemia (HP:0002149) | 2.79081399 |
70 | Increased purine levels (HP:0004368) | 2.79081399 |
71 | Cystic liver disease (HP:0006706) | 2.78613715 |
72 | Attenuation of retinal blood vessels (HP:0007843) | 2.77116207 |
73 | Vascular calcification (HP:0004934) | 2.77060222 |
74 | Lethargy (HP:0001254) | 2.73938174 |
75 | Large for gestational age (HP:0001520) | 2.68721714 |
76 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64898443 |
77 | Congenital, generalized hypertrichosis (HP:0004540) | 2.60955530 |
78 | Decreased circulating renin level (HP:0003351) | 2.60724932 |
79 | Hepatocellular carcinoma (HP:0001402) | 2.60296618 |
80 | Progressive inability to walk (HP:0002505) | 2.60254594 |
81 | Proximal tubulopathy (HP:0000114) | 2.58173816 |
82 | Furrowed tongue (HP:0000221) | 2.58086462 |
83 | Chorioretinal atrophy (HP:0000533) | 2.53569626 |
84 | Medial flaring of the eyebrow (HP:0010747) | 2.52522541 |
85 | Hypochromic microcytic anemia (HP:0004840) | 2.50422992 |
86 | Sensorimotor neuropathy (HP:0007141) | 2.50165061 |
87 | Alkalosis (HP:0001948) | 2.50153314 |
88 | Hypoglycemic seizures (HP:0002173) | 2.48783498 |
89 | Myocardial infarction (HP:0001658) | 2.48445854 |
90 | Birth length less than 3rd percentile (HP:0003561) | 2.47011347 |
91 | Clumsiness (HP:0002312) | 2.46808102 |
92 | Skin nodule (HP:0200036) | 2.46774379 |
93 | Spontaneous abortion (HP:0005268) | 2.43929873 |
94 | Cardiovascular calcification (HP:0011915) | 2.43709590 |
95 | Keratoconus (HP:0000563) | 2.42419686 |
96 | Increased corneal curvature (HP:0100692) | 2.42419686 |
97 | Protruding tongue (HP:0010808) | 2.38895118 |
98 | Cerebellar dysplasia (HP:0007033) | 2.36029830 |
99 | Cerebral edema (HP:0002181) | 2.35880744 |
100 | Abnormality of proline metabolism (HP:0010907) | 2.35239110 |
101 | Hydroxyprolinuria (HP:0003080) | 2.35239110 |
102 | Sclerocornea (HP:0000647) | 2.34652409 |
103 | Irritability (HP:0000737) | 2.33868624 |
104 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.33310404 |
105 | Absent/shortened dynein arms (HP:0200106) | 2.33310404 |
106 | Vomiting (HP:0002013) | 2.32822274 |
107 | Concave nail (HP:0001598) | 2.29984737 |
108 | Pancreatitis (HP:0001733) | 2.29630740 |
109 | Spastic diplegia (HP:0001264) | 2.29089370 |
110 | Systemic lupus erythematosus (HP:0002725) | 2.27925130 |
111 | Neonatal onset (HP:0003623) | 2.26161615 |
112 | Malnutrition (HP:0004395) | 2.23872809 |
113 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23079250 |
114 | Renal cortical cysts (HP:0000803) | 2.22568600 |
115 | Congenital hepatic fibrosis (HP:0002612) | 2.21204234 |
116 | Glycosuria (HP:0003076) | 2.20603288 |
117 | Abnormality of urine glucose concentration (HP:0011016) | 2.20603288 |
118 | Acanthocytosis (HP:0001927) | 2.17637249 |
119 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16941926 |
120 | Abnormality of the pons (HP:0007361) | 2.15135103 |
121 | Polyuria (HP:0000103) | 2.13902594 |
122 | Decreased central vision (HP:0007663) | 2.12984687 |
123 | Hyperventilation (HP:0002883) | 2.12813065 |
124 | Febrile seizures (HP:0002373) | 2.12525617 |
125 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.12232749 |
126 | Brushfield spots (HP:0001088) | 2.12020242 |
127 | Abnormality of the renal collecting system (HP:0004742) | 2.11645957 |
128 | Broad-based gait (HP:0002136) | 2.10969179 |
129 | Rickets (HP:0002748) | 2.09944187 |
130 | Abnormal biliary tract physiology (HP:0012439) | 2.09697615 |
131 | Bile duct proliferation (HP:0001408) | 2.09697615 |
132 | Male pseudohermaphroditism (HP:0000037) | 2.08466992 |
133 | Abnormal gallbladder morphology (HP:0012437) | 2.08317186 |
134 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07144635 |
135 | Patellar aplasia (HP:0006443) | 2.05210227 |
136 | Enlarged kidneys (HP:0000105) | 2.04407022 |
137 | Congenital sensorineural hearing impairment (HP:0008527) | 2.03724598 |
138 | Lissencephaly (HP:0001339) | 2.02889046 |
139 | Anencephaly (HP:0002323) | 2.02459991 |
140 | Hypoplasia of the pons (HP:0012110) | 2.01906251 |
141 | Cholelithiasis (HP:0001081) | 2.01876348 |
142 | Stomach cancer (HP:0012126) | 1.99990323 |
143 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99552824 |
144 | Generalized hypopigmentation of hair (HP:0011358) | 1.99170153 |
145 | Esophageal varix (HP:0002040) | 1.97604844 |
146 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.97124206 |
147 | Mitral stenosis (HP:0001718) | 1.95649001 |
148 | Late onset (HP:0003584) | 1.95456499 |
149 | Status epilepticus (HP:0002133) | 1.93891995 |
150 | Cholecystitis (HP:0001082) | 1.93422970 |
151 | Abnormal gallbladder physiology (HP:0012438) | 1.93422970 |
152 | Amelogenesis imperfecta (HP:0000705) | 1.93328209 |
153 | Tachypnea (HP:0002789) | 1.92858118 |
154 | Hyperglycemia (HP:0003074) | 1.92331101 |
155 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.90410463 |
156 | Duplicated collecting system (HP:0000081) | 1.89827616 |
157 | Gait imbalance (HP:0002141) | 1.89313838 |
158 | Severe muscular hypotonia (HP:0006829) | 1.87524003 |
159 | Hypophosphatemic rickets (HP:0004912) | 1.87386478 |
160 | Abnormal cartilage morphology (HP:0002763) | 1.85591520 |
161 | Nausea (HP:0002018) | 1.83588325 |
162 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.81455764 |
163 | Confusion (HP:0001289) | 1.80970709 |
164 | Fair hair (HP:0002286) | 1.79984267 |
165 | Pachygyria (HP:0001302) | 1.79977339 |
166 | Postaxial foot polydactyly (HP:0001830) | 1.79760539 |
167 | Amyloidosis (HP:0011034) | 1.79573457 |
168 | Hemiparesis (HP:0001269) | 1.78967014 |
169 | Congenital primary aphakia (HP:0007707) | 1.78047884 |
170 | Acute hepatic failure (HP:0006554) | 1.77770710 |
171 | Abnormality of vitamin metabolism (HP:0100508) | 1.76164090 |
172 | Hypothermia (HP:0002045) | 1.75968050 |
173 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75655751 |
174 | Glomerulonephritis (HP:0000099) | 1.75621884 |
175 | Dialeptic seizures (HP:0011146) | 1.75501184 |
176 | Abnormal urine output (HP:0012590) | 1.75442523 |
177 | Nephrolithiasis (HP:0000787) | 1.72505516 |
178 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.72496292 |
179 | Methylmalonic aciduria (HP:0012120) | 1.72289432 |
180 | Occipital encephalocele (HP:0002085) | 1.67766508 |
181 | Abnormality of macular pigmentation (HP:0008002) | 1.66079157 |
182 | Focal seizures (HP:0007359) | 1.65723528 |
183 | Absent speech (HP:0001344) | 1.65195103 |
184 | Nephrogenic diabetes insipidus (HP:0009806) | 1.64603384 |
185 | Optic nerve hypoplasia (HP:0000609) | 1.63786309 |
186 | Bilateral microphthalmos (HP:0007633) | 1.62708624 |
187 | Genital tract atresia (HP:0001827) | 1.62412404 |
188 | Short hallux (HP:0010109) | 1.60772361 |
189 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.60055659 |
190 | Methylmalonic acidemia (HP:0002912) | 1.58784596 |
191 | Focal motor seizures (HP:0011153) | 1.57171922 |
192 | Bulbous nose (HP:0000414) | 1.56282481 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.35810061 |
2 | ACVR1B | 3.93539030 |
3 | BMPR1B | 3.44330982 |
4 | SIK1 | 3.41792021 |
5 | ADRBK2 | 3.21639973 |
6 | INSRR | 2.79625195 |
7 | EPHA4 | 2.73291264 |
8 | MAP2K4 | 2.59349016 |
9 | GRK1 | 2.56664962 |
10 | FGFR4 | 2.56291051 |
11 | TAOK3 | 2.56043462 |
12 | ERN1 | 2.52041075 |
13 | ZAK | 2.51424603 |
14 | FRK | 2.33917294 |
15 | TLK1 | 2.32136958 |
16 | LATS1 | 2.20655727 |
17 | ERBB4 | 2.18989551 |
18 | OXSR1 | 2.14490264 |
19 | TRIB3 | 1.99424731 |
20 | WNK4 | 1.85743941 |
21 | WNK3 | 1.85043456 |
22 | MAP4K2 | 1.82140369 |
23 | NUAK1 | 1.79926334 |
24 | DAPK2 | 1.77043586 |
25 | CASK | 1.76136765 |
26 | MAPK13 | 1.71379595 |
27 | MST1R | 1.62791964 |
28 | STK38L | 1.50828723 |
29 | PKN2 | 1.50642695 |
30 | PINK1 | 1.47546767 |
31 | FGFR2 | 1.42434159 |
32 | ABL2 | 1.41590285 |
33 | PDK3 | 1.36128019 |
34 | PDK4 | 1.36128019 |
35 | TIE1 | 1.36002271 |
36 | MAPK11 | 1.32955964 |
37 | ADRBK1 | 1.31905229 |
38 | SGK2 | 1.30480550 |
39 | PNCK | 1.29527247 |
40 | TXK | 1.28437806 |
41 | CAMKK2 | 1.28157787 |
42 | MKNK2 | 1.27335153 |
43 | SGK3 | 1.24561965 |
44 | PRKAA2 | 1.24448089 |
45 | TGFBR1 | 1.22768064 |
46 | PIK3CG | 1.19869227 |
47 | BRSK2 | 1.16591614 |
48 | SGK223 | 1.16569855 |
49 | SGK494 | 1.16569855 |
50 | MAP3K4 | 1.13891384 |
51 | TNIK | 1.12735679 |
52 | MAP2K1 | 1.10777852 |
53 | KSR2 | 1.10203589 |
54 | MAPK15 | 1.09925559 |
55 | MAP3K7 | 1.06299733 |
56 | PHKG1 | 1.03138140 |
57 | PHKG2 | 1.03138140 |
58 | MAP3K2 | 1.01311870 |
59 | MAPKAPK3 | 0.97815602 |
60 | PDPK1 | 0.97555924 |
61 | JAK2 | 0.96759142 |
62 | MAP2K3 | 0.95458060 |
63 | LATS2 | 0.90447339 |
64 | MARK1 | 0.89382114 |
65 | MAP3K3 | 0.88889957 |
66 | NLK | 0.87214753 |
67 | PRKCE | 0.86228404 |
68 | TGFBR2 | 0.84641566 |
69 | PRKAA1 | 0.83426206 |
70 | WEE1 | 0.83118726 |
71 | PRKCZ | 0.81465862 |
72 | STK38 | 0.80582148 |
73 | MAP2K6 | 0.79785956 |
74 | RET | 0.78793697 |
75 | NTRK3 | 0.78332080 |
76 | STK39 | 0.78049011 |
77 | MAPK12 | 0.77991518 |
78 | PDK1 | 0.77679589 |
79 | NEK9 | 0.75008137 |
80 | ARAF | 0.74518430 |
81 | FLT3 | 0.74121663 |
82 | PTK6 | 0.73860889 |
83 | OBSCN | 0.73103875 |
84 | CAMK1D | 0.72732976 |
85 | PRKACG | 0.71307060 |
86 | CAMK2G | 0.71209421 |
87 | PDK2 | 0.70560235 |
88 | PTK2B | 0.69555807 |
89 | DYRK2 | 0.69356049 |
90 | TEC | 0.68717854 |
91 | MAP3K6 | 0.68221279 |
92 | MUSK | 0.67599467 |
93 | MAP3K9 | 0.67565828 |
94 | JAK1 | 0.67490328 |
95 | STK11 | 0.67199331 |
96 | TRPM7 | 0.64085669 |
97 | AKT3 | 0.63709952 |
98 | MAPK4 | 0.62863604 |
99 | FGFR3 | 0.61940266 |
100 | TAOK1 | 0.61464403 |
101 | MET | 0.61266259 |
102 | NTRK1 | 0.60711112 |
103 | CAMK1G | 0.59981405 |
104 | GSK3A | 0.57746631 |
105 | MAP2K7 | 0.56525659 |
106 | PRKCQ | 0.56360945 |
107 | MAP3K13 | 0.56064684 |
108 | PRKCG | 0.55888463 |
109 | TAF1 | 0.55381854 |
110 | CAMK1 | 0.53841096 |
111 | RPS6KA5 | 0.52890152 |
112 | IKBKB | 0.52729718 |
113 | TYK2 | 0.52647815 |
114 | MAP3K5 | 0.51223607 |
115 | CAMKK1 | 0.50420153 |
116 | PAK3 | 0.50271271 |
117 | PKN1 | 0.48158465 |
118 | CHUK | 0.47713993 |
119 | RPS6KA6 | 0.47486225 |
120 | ERBB3 | 0.47052758 |
121 | MAPK7 | 0.46929684 |
122 | GRK6 | 0.46262070 |
123 | RIPK1 | 0.45086817 |
124 | PTK2 | 0.44675772 |
125 | PRKACA | 0.43009426 |
126 | WNK1 | 0.42928611 |
127 | IGF1R | 0.42905479 |
128 | VRK1 | 0.42776620 |
129 | CAMK2A | 0.42333255 |
130 | BMPR2 | 0.42152563 |
131 | MAP3K1 | 0.41893345 |
132 | GRK7 | 0.41338301 |
133 | CSNK1G2 | 0.40008013 |
134 | IRAK3 | 0.38981095 |
135 | NTRK2 | 0.38288900 |
136 | MAPKAPK5 | 0.38140380 |
137 | TNK2 | 0.38110318 |
138 | PRKG1 | 0.37518947 |
139 | EPHA3 | 0.37470749 |
140 | SGK1 | 0.37369611 |
141 | KIT | 0.37227531 |
142 | PRKCH | 0.37104619 |
143 | NEK2 | 0.36931056 |
144 | IRAK2 | 0.36569001 |
145 | TRIM28 | 0.36233178 |
146 | PAK6 | 0.35326241 |
147 | CSNK1A1 | 0.34539274 |
148 | CSNK1D | 0.34389644 |
149 | GRK5 | 0.34271772 |
150 | IRAK1 | 0.34052341 |
151 | RIPK4 | 0.33424394 |
152 | MAP2K2 | 0.32653268 |
153 | PIK3CA | 0.32431041 |
154 | MINK1 | 0.31984257 |
155 | RAF1 | 0.31978765 |
156 | KDR | 0.31898903 |
157 | STK3 | 0.31857458 |
158 | CDK6 | 0.31518754 |
159 | FER | 0.31257409 |
160 | PRKCA | 0.29958888 |
161 | ERBB2 | 0.28844164 |
162 | CAMK4 | 0.28337569 |
163 | MKNK1 | 0.28210990 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.02044697 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51514254 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15411998 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11934893 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86307447 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.83855749 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76048408 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68154044 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60265416 |
10 | Phototransduction_Homo sapiens_hsa04744 | 2.53901184 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.52318877 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52300902 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48330074 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37377740 |
15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.33124389 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18136416 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.16465179 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15965291 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.04797200 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99279015 |
21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90429434 |
22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.89182102 |
23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.89168759 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87827288 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87303554 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84931695 |
27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.77607590 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72640696 |
29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.70835438 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68902180 |
31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.67244864 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62391012 |
33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62009332 |
34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61969669 |
35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60462848 |
36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58988763 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.57442236 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56485387 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55427043 |
40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48292884 |
41 | Homologous recombination_Homo sapiens_hsa03440 | 1.43701669 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43425885 |
43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42096374 |
44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41895342 |
45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37374228 |
46 | Taste transduction_Homo sapiens_hsa04742 | 1.36024684 |
47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33177257 |
48 | Morphine addiction_Homo sapiens_hsa05032 | 1.33038000 |
49 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31612841 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30971169 |
51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30942822 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30166743 |
53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29111637 |
54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27929759 |
55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26401522 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25952226 |
57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24821450 |
58 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21926755 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20923787 |
60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20553530 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16115099 |
62 | RNA polymerase_Homo sapiens_hsa03020 | 1.13915631 |
63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13859242 |
64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12836359 |
65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12575117 |
66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09651682 |
67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08336957 |
68 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06549701 |
69 | ABC transporters_Homo sapiens_hsa02010 | 1.04249498 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97461287 |
71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96674904 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95031232 |
73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93972427 |
74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92170359 |
75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91072933 |
76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90886188 |
77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90483456 |
78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88411286 |
79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85572054 |
80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.85402753 |
81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.84710628 |
82 | Lysine degradation_Homo sapiens_hsa00310 | 0.80252536 |
83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77954566 |
84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77908777 |
85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76988880 |
86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76441761 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74652641 |
88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70136689 |
89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69331575 |
90 | Salivary secretion_Homo sapiens_hsa04970 | 0.68435024 |
91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63999652 |
92 | Protein export_Homo sapiens_hsa03060 | 0.62801470 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62184708 |
94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61685988 |
95 | RNA degradation_Homo sapiens_hsa03018 | 0.59771162 |
96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56608581 |
97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54958829 |
98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51553944 |
99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50138518 |
100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45608448 |
101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43329200 |
102 | Purine metabolism_Homo sapiens_hsa00230 | 0.39272296 |
103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39204116 |
104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38882378 |
105 | Long-term depression_Homo sapiens_hsa04730 | 0.37709728 |
106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36842979 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36768291 |
108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35949723 |
109 | Renin secretion_Homo sapiens_hsa04924 | 0.35203939 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.34615818 |
111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34065291 |
112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33343903 |
113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31401864 |
114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28511796 |
115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26832512 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.21695107 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18967292 |
118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16681947 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16582136 |
120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14841709 |
121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13103765 |
122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08485415 |
123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05683761 |
124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.04093327 |
125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02930464 |
126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.02197131 |
127 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02117244 |
128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01904812 |
129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00613903 |
130 | Insulin secretion_Homo sapiens_hsa04911 | -0.1373605 |
131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.1271285 |
132 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1257786 |
133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1070362 |
134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1052898 |
135 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0952489 |
136 | Mineral absorption_Homo sapiens_hsa04978 | -0.0876180 |
137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0777418 |
138 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0718280 |
139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0699281 |
140 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0657951 |
141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0435616 |
142 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0305505 |
143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0270704 |
144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0206558 |